Cargando…

The etiology of cardiac hypertrophy in infants

This study aimed to describe the variety of etiologies currently identified in infants with cardiac hypertrophy (CH) and investigate whether there is a relation with hyperinsulinism, echocardiographic characteristics and prognosis. This retrospective cohort study included infants born between 2005 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stegeman, Raymond, Paauw, Nina D., de Graaf, Rosalie, van Loon, Rosa L. E., Termote, Jacqueline U. M., Breur, Johannes M. P. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134556/ https://www.ncbi.nlm.nih.gov/pubmed/34012105 http://dx.doi.org/10.1038/s41598-021-90128-3

Ejemplares similares

Neonatal cardiac hypertrophy: the role of hyperinsulinism—a review of literature
por: Paauw, Nina D., et al.
Publicado: (2019)

Cardiac Hypertrophy in Newborn Infants
por: Miller, Herbert C.
Publicado: (1944)

Neuroprotective Drugs in Infants With Severe Congenital Heart Disease: A Systematic Review
por: Stegeman, Raymond, et al.
Publicado: (2018)

Cardiac Hypertrophy Associated with Insulin Therapy in Extremely Preterm Infants
por: Dani, Carlo, et al.
Publicado: (2023)

Early motor outcomes in infants with critical congenital heart disease are related to neonatal brain development and brain injury
por: Stegeman, Raymond, et al.
Publicado: (2021)

CMR myocardial texture analysis tracks different etiologies of left ventricular hypertrophy
por: Schofield, Rebecca, et al.
Publicado: (2016)

Cardiac Hypertrophy and Dilatation
por: Davis, M. T.
Publicado: (1915)

Hypertrophied Tonsils and Adenoids an Etiological Factor in Backward Children
por: Cooper, Geo. H.
Publicado: (1910)

Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options
por: Sayin, Begum Yetis, et al.
Publicado: (2022)

Cardiac Hypertrophy
por: DaCosta,
Publicado: (1891)

Impact of hyperthyroidism on cardiac hypertrophy
por: Barreto-Chaves, M L M, et al.
Publicado: (2020)

Cardiac hypertrophy at autopsy
por: Basso, Cristina, et al.
Publicado: (2021)

Disproportionate cardiac hypertrophy during early postnatal development in infants born preterm
por: Aye, Christina Y L, et al.
Publicado: (2017)

Parental experiences of their infant’s hospital admission undergoing cardiac surgery: A systematic review
por: de Man, Marjorie A.C.P., et al.
Publicado: (2021)

Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman
por: Boguslavskyi, Andrii, et al.
Publicado: (2014)

Don’t judge the myocardium by its cover: The incremental value of cardiac magnetic resonance imaging in left ventricular hypertrophy
por: Parbhudayal, R. Y., et al.
Publicado: (2017)

Scientific evidence reveals conjoined etiology in spinal deformation and the need for etiology based treatment. Insight in a trail
por: Van Loon, Piet, et al.
Publicado: (2014)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

Potential Markers in Cardiac Hypertrophy?
por: Malinowski, Bartosz, et al.
Publicado: (2012)

Molecular biomarkers in cardiac hypertrophy
por: Zhu, Liu, et al.
Publicado: (2019)

MicroRNAs in Cardiac Hypertrophy
por: Wehbe, Nadine, et al.
Publicado: (2019)

Aneurism of Aorta with Cardiac Hypertrophy
Publicado: (1861)

The Microenvironment of the Pathogenesis of Cardiac Hypertrophy
por: Bazgir, Farhad, et al.
Publicado: (2023)

Role of FAK signaling in chagasic cardiac hypertrophy
por: Tucci, Amanda R., et al.
Publicado: (2020)

Cardiac Hypertrophy Involves Both Myocyte Hypertrophy and Hyperplasia in Anemic Zebrafish
por: Sun, Xiaojing, et al.
Publicado: (2009)

Role of Endothelin in the Induction of Cardiac Hypertrophy In Vitro
por: Bupha-Intr, Tepmanas, et al.
Publicado: (2012)

Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy
por: Schroen, Blanche, et al.
Publicado: (2007)

Hyperoxia-induced lung structure–function relation, vessel rarefaction, and cardiac hypertrophy in an infant rat model
por: Greco, Francesco, et al.
Publicado: (2019)

Longitudinal Motor-Developmental Outcomes in Infants with a Critical Congenital Heart Defect
por: Sprong, Maaike C. A., et al.
Publicado: (2022)

Epistasis regulates genetic control of cardiac hypertrophy
por: Wang, Qianru, et al.
Publicado: (2023)

Evaluation of cardiac hypertrophy in the setting of sudden cardiac death
por: Cunningham, Kristopher S., et al.
Publicado: (2019)

Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
por: Chen, Yan, et al.
Publicado: (2022)

THE CAPACITY OF THE CORONARY BED IN CARDIAC HYPERTROPHY
por: Dock, William
Publicado: (1941)

AN EXPERIMENTAL CONTRIBUTION TO THE STUDY OF CARDIAC HYPERTROPHY
por: Stewart, Hugh A.
Publicado: (1911)

Cardiac hypertrophy and thyroid hormone signaling
por: Dillmann, Wolfgang
Publicado: (2009)

cGKI signaling in cardiac hypertrophy
por: Lukowski, Robert, et al.
Publicado: (2009)

The function of miRNA in cardiac hypertrophy
por: Wang, Jian, et al.
Publicado: (2012)

Functions of Autophagy in Pathological Cardiac Hypertrophy
por: Li, Zhenhua, et al.
Publicado: (2015)

Case of Extreme Cardiac Hypertrophy and Dilatation
por: Smith, David B.
Publicado: (1871)

VCP represses pathological cardiac hypertrophy
por: Zhou, Ning, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b3qsh1aglcgm6gepimrke1mm75